CNNMoney.com
Companies Economy International Corrections Pre-market Trading After-hours Trading Winners/Losers/Actives Bonds Currencies Commodities World Markets Money Magazine Real Estate Taxes Jobs Ask the Expert Money 101 Autos Mutual Funds The Help Desk Loan Center Best Places to Live Ask the Expert Ultimate Guide to Retirement Retirement Calculators Rules of Retirement Best Funds Best Places to Retire Fortune Brainstorm Tech Apple 2.0 Blog Big Tech Blog Sectors and Stocks Tech Talk Resource Guide Small Business Makeovers Questions & Answers Small Business Video 100 Best Places to Launch FSB 100 Fortune Small Business Fortune 500 Brainstorm Tech Investing Management C-Suite Rankings Main Create Portfolio Edit Portfolio Create Alerts Edit Alerts
A Fresh Look at Pharma
By Erica Garcia

(MONEY Magazine) – Last spring regulators made the big brokerages agree to provide more independent stock research to customers. So where might Wall Street find some new insights? Would you believe India, by way of northeast Pennsylvania? Scranton's Life Science Analytics takes a page from the tech biz and uses workers in Hyderabad to collect news and data on health-care firms. Computers back home assign stocks scores for 30 key attributes. Among LSA's most revealing stats is the Total Clinical Index (TCI), which tracks the number of new drugs a company is developing and their chances of getting to market. Above, we've listed the four Big Pharma firms with the fattest pipelines, according to LSA. --ERICA GARCIA